<?xml version="1.0" encoding="UTF-8"?>
<p>The lemongrass (
 <italic>Cymbopogon citratus</italic> (DC.) Stapf), lavender (
 <italic>Lavandula dentata</italic> L.), sweet marjoram (
 <italic>Origanum majorana</italic> L.), and bay laurel (
 <italic>Laurus nobilis</italic> L.) essential oils were provided by different laboratories (see 
 <xref rid="antibiotics-10-00104-t001" ref-type="table">Table 1</xref>), where the dried aerial parts of the plants were hydrodistilled using a Clevenger apparatus, as recommended by the European Pharmacopeia. The lavandin (
 <italic>Lavandula hybrida</italic> E.Rev. ex Briq) and tea tree (
 <italic>Melaleuca alternifolia</italic> (Maiden &amp; Betche) Cheel) essential oils were from Flora Srl (Lorenzana, Pisa, Italy). The selection of these essential oils was based initially on their availability in our laboratory, and then on the studies in the literature that have reported in vitro activities of some of these against pathogen growth [
 <xref rid="B65-antibiotics-10-00104" ref-type="bibr">65</xref>,
 <xref rid="B66-antibiotics-10-00104" ref-type="bibr">66</xref>,
 <xref rid="B67-antibiotics-10-00104" ref-type="bibr">67</xref>].
</p>
